12/15-脂氧化酶基因敲除对肥胖相关性肾小球疾病模型小鼠肾组织的保护作用及其机制

doi:10.13481/j.1671-587X.20210601

摘要/Abstract

摘要： 目的

探讨12/15-脂氧化酶（12/15-LO）基因敲除（12/15-LOKO）对高脂饮食（HFD）诱导的肥胖小鼠肾组织的保护作用，阐明其在肾脏疾病进展中的作用。

方法

将16只12/15-LOKO小鼠和16只WT小鼠各自随机分为HFD组和标准饮食喂养（SFD）组，每组8只。HFD组小鼠给予HFD喂养，SFD组小鼠给予SFD喂养（即WT+HFD、WT+SFD、LOKO+HFD和LOKO+SFD组）。分别于喂养1、8和14周收集小鼠24 h尿液，14周后采血并处死小鼠。检测各组小鼠体质量、双肾质量和后腿胫骨长，分别在第1、8和14周时代谢笼收集各组小鼠24 h尿液，检测尿蛋白水平、尿蛋白肌酐比（PCR）和尿微量白蛋白肌酐比（ACR）。葡萄糖耐量试验（GTT）检测各组小鼠空腹血糖水平，实时定量逆转录PCR （RT-qPCR）法检测各组小鼠肾皮质组织中adiponectin、肿瘤坏死因子α（TNF-α）、白细胞介素6（IL-6）、单核细胞趋化蛋白 1（MCP-1）、纤溶酶原激活物抑制剂1（PAI-1）和转化生长因子β1（TGF-β1）mRNA表达水平，ELASA法检则各组小鼠血清中adiponectin、TNF-α、IL-6、血管紧张素Ⅱ（AngⅡ）和胰岛素水平。PAS染色观察小鼠肾组织病理形态表现，Western blotting法检测各组小鼠肾皮质组织中TGF-β1和PAI-1蛋白表达情况。

结果

HFD组小鼠体质量明显高于SFD组（P<0.01），肾脏质量和肾小球面积明显大于SFD组（P<0.01）；WT+HFD组小鼠ACR和PCR高于WT+SFD组（P<0.05）；与LOKO+HFD组比较，WT+HFD组小鼠空腹血糖水平升高（P<0.05），WT+HFD组小鼠肾皮质组织中TNF-α、IL-6和MCP-1 mRNA表达水平明显高于WT+SFD组（P<0.05）；与LOKO+HFD组比较，WT+HFD组小鼠肾皮质组织中IL-6和MCP-1 mRNA表达水平明显升高（P<0.05）， adiponectin mRNA表达水平降低（P<0.05）。WT+HFD组小鼠肾皮质组织中PAI-1和TGF-β1 mRNA表达水平高于WT+SFD组（P<0.05），LOKO+HFD组小鼠肾皮质中PAI-1和TGF-β1 mRNA表达水平明显低于WT+HFD组（P<0.01）。

结论

12/15-LOKO有利于改善肥胖小鼠胰岛素抵抗、蛋白尿水平和肾小球肥大程度，其机制可能与抑制TNF-α和IL-6等炎症因子在肾组织中的表达、影响PAI-1和TGF-β1 mRNA的表达、从而发挥肾脏保护作用有关。

关键词: 12/15-脂氧化酶, 肥胖, 肾小球疾病, 炎症

Abstract: Objective

To explore the protective effect of 12/15-lipoxygenase （12/15-LO） gene knockout（12/15-LOKO） on the kidney tissue of the obese mice induced by high-fat diet （HFD）， and to clarify its role in the progression of kidney disease.

Methods

A total of 16 12/15-LOKO mice and 16 WT mice were randomly divided into HFD group and standard diet （SFD） group，respectively，and there were 8 mice in each group. The mice in HFD group were fed with HFD，and the mice in SFD were fed with SFD， namely WT+HFD group， WT+SFD group， LOKO+HFD group， and LOKO+SFD group.The 24 h urine of mice in various groups was collected after feeding for 1， 8， and 14 weeks. The body weights， double kidney weights and tibia lengths of hind legs of mice in various groups were detected.The 24 h urine of the mice in various groups was collected after 1，8， and 14 week，the urinary protein level，urinary perotein creatinine ratios（PCR）， and urinary microalbumin creartinine ratio（ACR） of the mice were detected.The blood glucose levels of the mice in various groups were detected by glucose tolerance test （GTT），and the mRNA levels of adiponectin， tumor necrosis factor-α （TNF-α），interleukin-6 （IL-6），monocyte chemoattractant protein-1 （MCP-1）， plasminogen activator inhibitor-1 （PAI-1），and transforming growth factor-β1（TGF-β1） in kindey cortex tissue of the mice in various groups were detected by Real-time fluorescence quantitative PCR （RT-qPCR）method.ELISA method was used to detect the levels of adiponectin，TNF-α，IL-6，angioteinsinⅡ（AngⅡ）and insulin in serum of the mice in various groups.PAS staining was used to observe the pathomorphology of kidney tissue and glomerularareas of the mice in various groups，and Western blotting method was used to detect the expressions of TGF-β1 and PAI-1β proteins in kidney tissue of the mice in various groups.

Results

The body weight， kidney weight and glomerular area of the mice in HFD group were significantly higher than those in SFD group （P<0.01），and the ACR and PCR of the mice in WT+HFD group were higher than those in SFD group （P<0.05）； compared with LOKO+HFD group， the fasting blood glucose level of the mice in WT+HFD group was increased （P<0.05）. The expression levels of TNF- α，IL-6，and MCP-1 mRNA in kidney cortex tissue of the mice in WT+HFD group were significantly higher than those in WT+SFD group （P<0.05）. Compared with LOKO+HFD group，the expression levels of IL-6 and MCP-1 mRNA in kidney cortex tissue of the mice in WT+HFD group were increased（P<0.05）， while the expression level of adiponectin mRNA was decreased significantly （P<0.05）. The expression levels of PAI-1 and TGF-β1 mRNA in kidney cortex tissue of the mice in WT+HFD group were higher than those of the mice in WT+SFD group（P<0.05）.The expression levels of PAI-1 and TGF-β1 mRNA in kidney cortex tissue of the mice in LOKO+HFD group were lower than those of the mice in WT+HFD group（P<0.01）.

Conclusion

12/15-LOKO can improve insulin resistance， proteinuria level and degree of glomerular hypertrophy of the obese mice， and its mechanism may be related to the inhibition the expressions of inflammatory factors such as TNF- α and IL-6 in kidney tissue and affecting the expressions of PAI-1 and TGF-β1 mRNA，so as to play a protective role in kidney.

Key words: 12/15-lipoxygenase, obesity, glomerular disease, inflammation

中图分类号:

R692.6

任咪咪,高梦寒,王婧,赖佳美,于金宇,远航. 12/15-脂氧化酶基因敲除对肥胖相关性肾小球疾病模型小鼠肾组织的保护作用及其机制[J]. 吉林大学学报(医学版), 2021, 47(6): 1337-1346.

Mimi REN,Menghan GAO,Jing WANG,Jiamei LAI,Jinyu YU,Hang YUAN. Protective effect of 12/15-lipoxygenase gene knockout on kidney tissue of obesity-related glomerulopathy model mice and its mechanism[J]. Journal of Jilin University(Medicine Edition), 2021, 47(6): 1337-1346.

图/表 11

表1

图1

图2

图3

图4

图5

图6

图7

图8

图9

图10

参考文献 21

1	COLLINS A J， FOLEY R N， HERZOG C， et al. Excerpts from the US renal data system 2009 annual data report［J］. Am J Kidney Dis， 2010， 55（1）： A6-A7.
2	CAO H. Adipocytokines in obesity and metabolic disease［J］. J Endocrinol， 2014， 220（2）： T47-T59.
3	CHAGNAC A， WEINSTEIN T， KORZETS A， et al. Glomerular hemodynamics in severe obesity［J］. Am J Physiol Ren Physiol， 2000， 278（5）： F817-F822.
4	XU H Z， CHENG Y L， WANG W N，et al. 12-lipoxygenase inhibition on microalbuminuria in type-1 and type-2 diabetes is associated with changes of glomerular angiotensin II type 1 receptor related to insulin resistance［J］. Int J Mol Sci， 2016， 17（5）： 684.
5	DOBRIAN A D， MORRIS M A， TAYLOR-FISHWICK D A， et al. Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complications［J］. Pharmacol Ther， 2019， 195： 100-110.
6	YUAN H， REDDY M A， DESHPANDE S， et al. Epigenetic histone modifications involved in profibrotic gene regulation by 12/15-lipoxygenase and its oxidized lipid products in diabetic nephropathy［J］. Antioxid Redox Signal， 2016， 24（7）： 361-375.
7	TERSEY S A， MAIER B， NISHIKI Y， et al. 12-lipoxygenase promotes obesity-induced oxidative stress in pancreatic islets［J］. Mol Cell Biol， 2014， 34（19）： 3735-3745.
8	TRAJCEVSKI K E， O’NEILL H M， WANG D C，et al.Enhanced lipid oxidation and maintenance of muscle insulin sensitivity despite glucose intolerance in a diet-induced obesity mouse model［J］. PLoS One， 2013， 8（8）： e71747.
9	YEUNG J， HOLINSTAT M. 12-lipoxygenase： a potential target for novel anti-platelet therapeutics［J］. Cardiovasc Hematol Agents Med Chem，2011，9（3）： 154-164.
10	LOPATEGI A， LÓPEZ-VICARIO C， ALCARAZ-QUILES J， et al. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction［J］. Mol Cell Endocrinol， 2016， 419： 44-59.
11	CHAKRABARTI S K， WEN Y， DOBRIAN A D，et al. Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats［J］.Am J Physiol Endocrinol Metab，2011，300（1）： E175-E187.
12	MA K， NUNEMAKER C S， WU R，et al. 12-lipoxygenase products reduce insulin secretion and β-cell viability in human islets［J］. J Clin Endocrinol Metab， 2010，95（2）： 887-893.
13	HERNANDEZ-PEREZ M， CHOPRA G， FINE J，et al. Inhibition of 12/15-lipoxygenase protects against β-cell oxidative stress and glycemic deterioration in mouse models of type 1 diabetes［J］. Diabetes， 2017， 66（11）： 2875-2887.
14	UYSAL K T， WIESBROCK S M， HOTAMISLIGIL G S.Functional analysis of tumor necrosis factor （TNF） receptors in TNF-α-mediated insulin resistance in genetic obesity［J］. Endocrinology， 1998， 139（12）： 4832-4838.
15	KUME S， UZU T， ARAKI S， et al. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet［J］. J Am Soc Nephrol， 2007， 18（10）： 2715-2723.
16	ROUBICEK T， BARTLOVA M， KRAJICKOVA J， et al. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease［J］. Nutrition， 2009， 25（7/8）： 762-768.
17	LIAO M T， SUNG C C， HUNG K C， et al. Insulin resistance in patients with chronic kidney disease［J］. J Biomed Biotechnol， 2012， 2012： 691369.
18	PARVANOVA A I， TREVISAN R， ILIEV I P， et al. Insulin resistance and microalbuminuria： a cross-sectional， case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion［J］. Diabetes， 2006， 55（5）： 1456-1462.
19	CUSUMANO A M， BODKIN N L， HANSEN B C， et al. Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys［J］. Am J Kidney Dis， 2002， 40（5）： 1075-1085.
20	ABRASS C K， RAUGI G J， GABOUREL L S， et al. Insulin and insulin-like growth factor I binding to cultured rat glomerular mesangial cells［J］. Endocrinology， 1988， 123（5）： 2432-2439.
21	CHAKRABARTI S K， COLE B K， WEN Y， et al. 12/15-lipoxygenase products induce inflammation and impair insulin signaling in 3T3-L1 adipocytes［J］. Obesity （Silver Spring）， 2009， 17（9）： 1657-1663.

Primer	Sequence
Adiponectin (M)	Forward:GTTGCAAGCTCTCCTGTTCC Reverse:TCTCCAGGAGTGCCATCTCT
TNF-α (M)	Forward:TGTTGCCTCCTCTTTTGCTT Reverse:TGGTCACCAAATCAGCGTTA
IL-6 (M)	Forward:ACAAAGCCAGAGTCCTTC Reverse:ACCACAGTGAGGAATGTCCAC
MCP-1 (M)	Forward:TTAAAAACCTGGATCGGAACC Reverse:GCATTAGCTTCAGATTTACGG
PAI-1 (M)	Forward:GACGCCTTCATTTGGACGAA Reverse:CGGACCTTTTCCCTTCAAGAGTCCG
TGF-β1 (M)	Forward:AGGAAGGACCTGGGTTGGAAG Reverse:CGTCTCGACCCACGTAGTAGACG
CTGF (M)	Forward:CAGCTCCGAGAAGGGTCAAGCTG Reverse:AACAGGCGCTCCACTCTGTG
COL 1a1 (M)	Forward:CGGATAGCAGATTGAGAACATCCG Reverse:CGGCTGAGTAGGGAACACACA
β-actin (R/M)	Forward:CCCTGTATGCCTCTGGTCGT Reverse:CGGACGCAGCTCAGTAACAGTCCG

[1]	沈鑫,刘洋,陈泓宇,张洁,程庆砾,杨光. 高糖通过miR-125b对小鼠RAW264.7巨噬细胞极化的调控作用[J]. 吉林大学学报(医学版), 2022, 48(4): 847-857.
[2]	黄爽,陈琛,黄波. 柠檬苦素对营养性肥胖大鼠脂质代谢和肠道菌群的影响[J]. 吉林大学学报(医学版), 2022, 48(4): 858-865.
[3]	万朝辉,曾良,周辉,李晶,雷长城. 重楼皂苷Ⅶ通过抑制NF-κB信号通路对重症急性胰腺炎大鼠急性肺损伤的保护作用[J]. 吉林大学学报(医学版), 2022, 48(3): 668-675.
[4]	蒋孙班,康思思,赵利娜,王朝,蒋丽娜. TLRs信号通路和TLRs的Cross-talk在炎症性疾病中作用的研究进展[J]. 吉林大学学报(医学版), 2022, 48(3): 825-831.
[5]	李艳青,赵方,高蕊,吴昕,牛小斌. 通管消癥饮对输卵管炎性不孕症模型大鼠血清炎症因子水平的影响及其机制[J]. 吉林大学学报(医学版), 2022, 48(2): 383-390.
[6]	田悦,陈慧珊,张佩佩,申玉芹. 血管内皮生长因子在牙周组织再生中作用的研究进展Research progress in effect of vascular endothelial growth factor in periodontal tissue regeneration[J]. 吉林大学学报(医学版), 2022, 48(2): 546-552.
[7]	韩娜,刘凡平,田彦卿,郑志清,郎伟明,王倩,刘亚涛,朱建光. miRNA-27a对实验性肺结核大鼠免疫功能的调控作用及其机制[J]. 吉林大学学报(医学版), 2022, 48(1): 104-110.
[8]	苏松,王洪波,马瑜聪,方昕,刘俊荣,乔红梅. 川崎病并发咽旁间隙炎性改变1例报告及文献复习[J]. 吉林大学学报(医学版), 2022, 48(1): 228-233.
[9]	李聪,赵坤,张景良,张英杰,王洪新. 黄芪多糖对野百合碱诱导的肺动脉高压大鼠肺动脉血管的保护作用及其机制[J]. 吉林大学学报(医学版), 2021, 47(6): 1371-1379.
[10]	何勇,洪莉,黄国涛,赵芷涵. 棕榈酸对骨骼肌细胞脂质沉积的诱导作用[J]. 吉林大学学报(医学版), 2021, 47(6): 1380-1385.
[11]	龚泽华,刘俊杰,徐继伟,李建民. 头孢曲松对蛛网膜下腔出血大鼠星形胶质细胞活化和炎症反应的影响[J]. 吉林大学学报(医学版), 2021, 47(6): 1462-1468.
[12]	龚杰,雷泽华,张远威,黄雄,杜波,王志旭. miR-490-3p过表达对大鼠非酒精性脂肪性肝病的改善作用及其机制[J]. 吉林大学学报(医学版), 2021, 47(6): 1495-1501.
[13]	赵岩,于鹏程,王禹,王英平,李平亚,刘金平. 人参二醇诱导3T3-L1脂肪前体细胞凋亡及其作用机制[J]. 吉林大学学报(医学版), 2021, 47(5): 1154-1161.
[14]	朱丽艳,王耀明,秦政,赵欢欢,王增颖,杨秀红. 血管紧张素(1-7)对小鼠肢体缺血再灌注所致肾损伤的改善作用及其机制[J]. 吉林大学学报(医学版), 2021, 47(4): 834-841.
[15]	武豪杰,张明辉,洪成智. 薯蓣皂苷对滑膜炎大鼠症状的改善作用和对TLR2-NF-κB信号通路的调节作用及其机制[J]. 吉林大学学报(医学版), 2021, 47(4): 943-950.